Liu D, McManus R M, Ryan E A
Department of Medicine, University of Alberta, Edmonton.
Clin Invest Med. 1996 Apr;19(2):71-82.
This study of patients with insulin-dependent diabetes mellitus (IDDM) and hypoglycemia unawareness examines the effect of a period of less strict glycemic control on the defective counter-regulatory hormonal responses to and impaired awareness of hypoglycemia. In seven patients with IDDM with strict glycemic control and hypoglycemia unawareness, responses were studied with the use of a hyperinsulinemic hypoglycemic clamp test before and after 3 months of test treatment, which aimed at increasing daily mean blood glucose levels to 8 to 10 mmol/L, based on self-monitoring four times per day. The 3 months of test treatment elevated the patients' levels of glycosylated hemoglobin HbAlc from a mean of 6.9% (standard error [SE] 0.3%) at baseline to 8.0% (SE 0.3%, p < 0.05) and decreased the number of episodes of hypoglycemia (blood glucose level less than 3.0 mmol/L) per patient from a mean of 4.7 (SE 1.3) per week to 1.9 (SE 0.5) per week (p < 0.05). Although the same nadir (2.2 mmol/L) and duration of hypoglycemia were reached during each of the two clamp tests, the scores for sweating and lack of concentration were improved (p < 0.05) at the second test. The release of growth hormone and epinephrine during hypoglycemia were significantly improved (p < 0.05) at the second test, whereas the glucagon, cortisol and norepinephrine responses were unchanged. There were no significant differences in the results of the autonomic and cognitive function tests between the two tests. The results suggest that impaired hormonal and symptomatic responses to hypoglycemia in IDDM can be partially reversed by a modest rise in glucose levels for 3 months.
这项针对胰岛素依赖型糖尿病(IDDM)和低血糖无意识症患者的研究,探讨了一段时期内不太严格的血糖控制对低血糖时缺陷性的反调节激素反应及低血糖意识受损的影响。在7例血糖控制严格且有低血糖无意识症的IDDM患者中,在为期3个月的试验性治疗前后,采用高胰岛素低血糖钳夹试验研究反应情况。试验性治疗旨在根据患者每天4次的自我监测,将每日平均血糖水平提高到8至10 mmol/L。3个月的试验性治疗使患者糖化血红蛋白HbAlc水平从基线时的平均6.9%(标准误[SE] 0.3%)升至8.0%(SE 0.3%,p<0.05),并使每位患者低血糖发作次数(血糖水平低于3.0 mmol/L)从平均每周4.7次(SE 1.3)降至每周1.9次(SE 0.5)(p<0.05)。虽然在两次钳夹试验中达到的低血糖最低点(2.2 mmol/L)和持续时间相同,但在第二次试验时,出汗和注意力不集中的评分有所改善(p<0.05)。在第二次试验时,低血糖期间生长激素和肾上腺素的释放明显改善(p<0.05),而胰高血糖素、皮质醇和去甲肾上腺素的反应未改变。两次试验之间自主神经和认知功能测试结果无显著差异。结果表明,IDDM患者对低血糖的激素和症状反应受损可通过3个月适度提高血糖水平而部分逆转。